Home » Belgium » Page 4

Belgium

Side event. Innovation responses to promoting access to controlled medicines, while preventing diversion and non-medical use: Following up on the global “access and availability” campaign led by the chair of the 65th CND

Organised by Belgium with the support of Australia, Austria, Bulgaria, Croatia, Cyprus, Czechia, Denmark, El Salvador, Estonia, Finland, France, Germany, Ghana, Greece, Hungary, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, the Netherlands, Poland, Portugal, Romania, Slovakia, Slovenia, South Africa, Spain, Sweden, Switzerland, the United States, the European Union, the UNODC Prevention, Treatment and Rehabilitation Section, the …

Read more

Side Event: Time is of the Essence, Reigniting Efforts for Scaling up Implementation of International Drug Policy Commitments to Improve the Ability of and Access to Controlled Substances for Medical and Scientific Purposes

Organized by the Union for International Cancer Control with the support of Australia, Belgium, Mexico, the Netherlands, the UNODC Prevention, Treatment and Rehabilitation Section, the Asia Pacific Hospice Palliative Care Network, Walther Global Palliative Care and Supportive Oncology, the African Palliative Care Association, the World Hospice Palliative Care Alliance and the International Association for Hospice …

Read more

Resolution L3. Promoting alternative development as a development-oriented drug control strategy, taking into account measures to protect the environment and recognizing the rights of Indigenous Peoples

Monday afternoon 4.45pm Peru: Thank you very much, Mr. Chair and good afternoon, dear colleagues. We’ve been working this afternoon just a few minutes ago on L3, Mr. Chair, and I’m happy to tell you that we have a good advance. We have an important  number of para already agreed in informals. And even though …

Read more

Resolution L5. Strengthening information-sharing to increase international scheduling and the implementation of scheduling decisions

Monday afternoon session  Chair: It is my pleasure to chair the session of this committee. And I’m confident that we would work together to bring the important work of the committee to good results in accordance with the agenda and organization of work contained in document L1. This committee would have eight meetings starting this …

Read more

Plenary Items 1, 2, 3 – Opening of the 66th session of the Commission on Narcotic Drugs

OPENING OF THE SIXTY-SIXTH SESSION OF THE COMMISSION ON NARCOTIC DRUGS Secretary: [Organizational and administrative disclaimers for online participants] Chair: [Opening statement – no interpretation] Item 1. Chair: The extended bureau held three meetings this year to address organizational matters that were also discussed during the pre-consultation sessions. I thank all the participants. I also …

Read more

CND 65th Reconvened Session – 9th December 2022

Reconvened Sixty-fifth session of the Commission on Narcotic Drugs, Vienna, Austria, 8-9 December 2022 Chair: Welcome back. Secretariat: (Reminder on COVID safety measures in Vienna) Agenda item 4. – Strategic management, budgetary and administrative questions Chair: We considered our consolidated budget yesterday. We, as a commission, are now required to take action. There have been …

Read more